Author

Josef Messinger

Institution: Orion Corporation (Finland)

Observed institution: Orion Corporation (Finland)

ORCID: 0000-0001-7920-0571

Observed ORCID: 0000-0001-7920-0571

OpenAlex ID: A5023597969

The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes

2020 · Jean Quancard, Brian Cox, et al. · ChemMedChem · 19

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery

2021 · Jean Quancard, Anders Bach, et al. · ChemMedChem · 15

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation

2023 · Jean Quancard, Anna Vulpetti, et al. · ChemMedChem · 13

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead

2025 · Jean Quancard, Anders Bach, et al. · ChemMedChem · 8

Cover Feature: The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead (ChemMedChem 8/2025)

2025 · Jean Quancard, Anders Bach, et al. · ChemMedChem

意欲消失と表現力の欠乏による陰性症状現象学の解明:dsm-5と精神分裂症調査との関連 | 文献情報 | J-global 科学技術総合リンクセンター

2011 · Josef Messinger, Fabien Trémeau, et al. · Clinical Psychology Review

Works count: 6

Citation count: 55

H-index: 4

I10-index: 3